Ying Z Mazzu

5PUBLICATIONS
17CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 10, 2022
Increased MYBL2 expression in aggressive hormone-sensitive prostate cancer.

Yuki Yoshikawa, Konrad H Stopsack, Xin Victoria Wang

|Jun 07, 2022
The Impact of PIK3R1 Mutations and Insulin-PI3K-Glycolytic Pathway Regulation in Prostate Cancer.

Goutam Chakraborty, Subhiksha Nandakumar, Rahim Hirani

|Nov 21, 2021
Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancer.

Ying Z Mazzu, Yu-Rou Liao, Subhiksha Nandakumar

|Nov 18, 2021
Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity.

Ying Z Mazzu, YuRou Liao, Subhiksha Nandakumar

|May 10, 2020
Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer.

Ying Z Mazzu, Joshua Armenia, Subhiksha Nandakumar

Pageof 1